Liver Disease Treatment at the Center for Liver Disease and Transplantation

The CLDT's experts in the fields of hepatology, liver surgery, and transplantation offer extensive experience treating all forms and stages of liver disease. We can assess and treat your current disease with standard medical therapy, investigational protocols, surgical therapy, or transplantation.

For your evaluation, you will meet with a specially-trained gastroenterologist called a hepatologist, who will determine the extent of liver damage and perform blood tests, including a test to see if a hepatitis virus is active in the blood stream. On occasion, a liver biopsy or a new non-invasive test called the Fibroscan is performed to determine how much damage the liver has sustained. This information assists your physician in determining the best course of treatment for you, and how aggressive the treatment regimen should be.

The CLDT continually pursues clinical trials studying various treatment regimens for viral hepatitis and immunosuppressive therapy for liver transplantation. Currently, more than 30 clinical trials are underway involving antiviral treatment for Hepatitis C and Hepatitis B, including Phase II through IV industry-sponsored trials. The Center also participates in trials of artificial liver support devices for acute and chronic liver failure and studies of novel immunosuppressive and antiviral medications following liver transplantation.

Our patients are invited to participate in trials of new treatments where appropriate, but participation is entirely voluntary.

Learn about our care for patients with the following liver diseases in the sections below.